NetworkNewsBreaks – AVAIL Vapor Announces PMTA Acceptance from FDA for e-Liquid Nicotine Offerings
AVAIL Vapor, a leading premium U.S. retailer, has received its first Premarket Tobacco Application (“PMTA”) acceptance from the U.S. Food and Drug Administration (“FDA”). The PMTA was received for AVAIL’s e-liquid nicotine product line. The company is in the process of filing several similar applications before the Sept. 9, 2020, PMTA deadline in line with its strategy to offer a variety of products to adults seeking alternative choices to combustible tobacco products. The e-liquid nicotine product application will now enter the substantive scientific review stage, during which the FDA will identify whether AVAIL has proven that its nicotine vaping products…







